Detalhe da pesquisa
1.
Transcriptionally-active "defective" HIV-1 proviruses and their association with immunological non-response to antiretroviral therapy.
J Infect Dis
; 2024 Jan 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-38226493
2.
Defective HIV-1 proviruses produce viral proteins.
Proc Natl Acad Sci U S A
; 117(7): 3704-3710, 2020 02 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32029589
3.
A Combination of Amino Acid Mutations Leads to Resistance to Multiple Nucleoside Analogs in Reverse Transcriptases from HIV-1 Subtypes B and C.
Antimicrob Agents Chemother
; 66(1): e0150021, 2022 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34723625
4.
2021 update to HIV-TRePS: a highly flexible and accurate system for the prediction of treatment response from incomplete baseline information in different healthcare settings.
J Antimicrob Chemother
; 76(7): 1898-1906, 2021 06 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33792714
5.
Antigenic Restimulation of Virus-Specific Memory CD8+ T Cells Requires Days of Lytic Protein Accumulation for Maximal Cytotoxic Capacity.
J Virol
; 94(23)2020 11 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-32907983
6.
Defective HIV-1 proviruses produce novel protein-coding RNA species in HIV-infected patients on combination antiretroviral therapy.
Proc Natl Acad Sci U S A
; 113(31): 8783-8, 2016 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27432972
7.
Clonally expanded CD4+ T cells can produce infectious HIV-1 in vivo.
Proc Natl Acad Sci U S A
; 113(7): 1883-8, 2016 Feb 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-26858442
8.
2018 update to the HIV-TRePS system: the development of new computational models to predict HIV treatment outcomes, with or without a genotype, with enhanced usability for low-income settings.
J Antimicrob Chemother
; 73(8): 2186-2196, 2018 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29889249
9.
Lytic granule loading of CD8+ T cells is required for HIV-infected cell elimination associated with immune control.
Immunity
; 29(6): 1009-21, 2008 Dec 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-19062316
10.
Transmitted HIV Drug Resistance Is High and Longstanding in Metropolitan Washington, DC.
Clin Infect Dis
; 63(6): 836-843, 2016 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-27307507
11.
Lack of detectable HIV-1 molecular evolution during suppressive antiretroviral therapy.
PLoS Pathog
; 10(3): e1004010, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24651464
12.
HIV populations are large and accumulate high genetic diversity in a nonlinear fashion.
J Virol
; 87(18): 10313-23, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23678164
13.
Comprehensive analysis of unique cases with extraordinary control over HIV replication.
Blood
; 119(20): 4645-55, 2012 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-22490332
14.
The CD8+ HLA-DR+ T cells expanded in HIV-1 infection are qualitatively identical to those from healthy controls.
Eur J Immunol
; 42(10): 2608-20, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22777759
15.
Microalbuminuria in HIV disease.
Am J Nephrol
; 37(5): 443-51, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23615312
16.
CD4 and CD8 T cell immune activation during chronic HIV infection: roles of homeostasis, HIV, type I IFN, and IL-7.
J Immunol
; 186(4): 2106-16, 2011 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21257970
17.
Decreased interleukin 7 responsiveness of T lymphocytes in patients with idiopathic CD4 lymphopenia.
J Infect Dis
; 205(9): 1382-90, 2012 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-22454463
18.
Immune reconstitution inflammatory syndrome drives emergence of HIV drug resistance from multiple anatomic compartments in a person living with HIV.
Nat Med
; 29(6): 1364-1369, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37322122
19.
Long-term persistence of transcriptionally active 'defective' HIV-1 proviruses: implications for persistent immune activation during antiretroviral therapy.
AIDS
; 37(14): 2119-2130, 2023 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37555786
20.
High dose atorvastatin decreases cellular markers of immune activation without affecting HIV-1 RNA levels: results of a double-blind randomized placebo controlled clinical trial.
J Infect Dis
; 203(6): 756-64, 2011 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21325137